zolpidem has been researched along with Kussmaul Aphasia in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shyu, C | 1 |
| Burke, K | 1 |
| Souweidane, MM | 1 |
| Dunkel, IJ | 1 |
| Gilheeney, SW | 1 |
| Gershon, T | 1 |
| Khakoo, Y | 1 |
1 other study available for zolpidem and Kussmaul Aphasia
| Article | Year |
|---|---|
Novel use of zolpidem in cerebellar mutism syndrome.
Topics: Cerebellar Diseases; Cerebellar Neoplasms; Child, Preschool; Female; GABA-A Receptor Agonists; Human | 2011 |